been observed in rodent models of IUCE. 5 It is interesting that upregulation of proapoptotic proteins has been reported to occur in cerebral cortex of IUCE fetal mice relative to controls. [6] [7] [8] IUCE has been associated with diminished neuronal density and altered cortical organization of postnatal brain in nonhuman primates 9 ; however, the validity of extrapolating these results from mammalian models to humans remains unclear. Animal studies involve known dosages of single, pure drug preparations administered at precisely defined points in gestation. In contrast to animal studies, human studies of cocaine use by pregnant women present additional analytic challenges that consist not only of widely varying drug concentration, purity, and patterns of use during pregnancy but also of concurrent cigarette, alcohol, or marijuana use during the course of the pregnancy [10] [11] [12] The effect of variability in the pattern of human intrauterine exposures is exacerbated by differences in social and clinical risk factors between cocaine-using and nonusing pregnant women, which can be statistically but not experimentally controlled. 13 Concern about structural consequences of these intrauterine exposures is heightened by an ample literature that documents cognitive and behavioral consequences associated with prenatal exposures to cocaine, alcohol, cigarettes, or marijuana. Some, although not all, neurobehavioral studies of infants, toddlers, and children with IUCE reported deficits in language development, early executive function, learning, and self-regulation. [14] [15] [16] [17] [18] Prenatal exposure to alcohol has been associated with cognitive and behavioral deficits in executive function, processing speed, and inattentiveness that persist into childhood even in children without stigmata of fetal alcohol syndrome (FAS). [19] [20] [21] [22] Human newborns with intrauterine nicotine exposure demonstrated increased tone and excitability as compared with control infants, 23 delayed babbling at 8 months of age, 24 increased impulsivity as young children, and working memory and visuospatial skills deficits throughout childhood. [25] [26] [27] An inverse relationship between prenatal cigarette exposure and general intelligence persisted into adolescence. 28 Children with intrauterine marijuana exposure have demonstrated poorer scores on intelligence tests, 29, 30 increased impulsivity, hyperactivity, decreased attentiveness, increased rates of delinquency, and externalizing problems 26, [31] [32] [33] [34] [35] Thus, investigation of the effect of 1 prenatal exposure on subsequent brain structure and function must take into consideration the contributions of other prenatal exposures. In this study, we acquired volumetric MRI data and applied quantitative segmentation techniques to evaluate potential differences in brain tissue volumes of children with and without IUCE while adjusting for intrauterine exposures to alcohol, cigarettes, and marijuana.
METHODS

Participants
The parent sample was recruited by trained interviewer/ recruiters who screened maternity and nursery charts 7 days a week on the postpartum floor of Boston City Hospital, from October 1990 to March 1993, using informed consent and protocols approved by the Boston Medical Center institutional review board. Potential participants for the IUCE group were initially identified by review of medical charts for mother's report of cocaine use in pregnancy or positive prenatal or postnatal urine drug screen for cocaine metabolites from mother or infant. Unexposed dyads roughly comparable to cocaineexposed mother-infant dyads in ethnicity (African American/African Caribbean versus other) were preferentially approached for recruitment soon after delivery. All mother-infant dyads met the following criteria: (1) infant gestational age Ն36 weeks; (2) no NICU care; (3) no major congenital malformation; (4) no diagnosis of FAS in the neonatal chart or physical examination; (5) no history of HIV seropositivity in mother's or infant's medical chart; (6) mother's ability to communicate fluently in English; (7) no neonatal or maternal urine drug screen or medical chart evidence of mother's use during pregnancy of illegal opiates, methadone, amphetamines, phencyclidine, barbiturates, or hallucinogens; and (8) mother's age Ն18 years. Additional details about sample characteristics and recruitment are reported elsewhere. 36 Mothers who participated in the study were identified as either lighter users, heavier users, or nonusers of cocaine by interview and biological markers obtained by clinicians and study personnel. Meconium specimens from enrolled infants were analyzed by radioimmunoassay for the cocaine metabolite benzoylecgonine, opiates, amphetamines, benzodiazepines, and cannabinoids using a modified method of Ostrea, published in detail elsewhere. 36, 37 During the period of study recruitment at Boston Medical Center, urine testing for metabolites of illicit drugs was performed for clinical indications at the discretion of health care personnel but was not universal. Clinical indications at the time included no prenatal care, a jittery infant, unusual maternal behavior, or a known history of substance use. When available in the medical chart, we documented the results of urine drug enzyme-multiplied immunoassay technique assays obtained for clinical purposes during prenatal or perinatal care of mother or infant. After recruitment and written informed consent, we collected additional urine samples from study mothers to determine benzoylecgonine, opiates, amphetamines, benzodiazepines, and cannabinoids by radioimmunoassay using commercial kits (Abuscreen RIA; Roche Diagnostics Systems, Inc, Montclair, NJ). Participants were protected by a writ of confidentiality.
Exposure Classification
All exposed or unexposed mother-infant dyads had at least 1 biological marker, either urine from mother or infant or meconium, to identify their exposure or lack of exposure to cocaine during pregnancy. In the parent sample, the mean days of self-reported cocaine use during pregnancy was 20.6 days (range: 0 -264 days). The mean meconium concentration was 1143 ng of benzoylecgonine/gram of meconium (range: 0 -17 950 ng/g). The sample median was 1100 ng/g in meconium at birth or 9 days of self-reported use during pregnancy. Before source study data were analyzed, a composite measure of heavier use was a priori defined as the top quartile of meconium concentration for cocaine metabolites (benzoylecgonine Ͼ3314 ng/g meconium) and/or top quartile days of self-reported use (Ͼ61 days) during the entire pregnancy. All other use was classified as "lighter." By this method, 45 users (33% of the users) were classified as heavier users. All other users (n ϭ 93) were classified as "lighter users."
Pragmatic as well as scientific considerations influenced this either/or definition of exposure level. Women are more likely to underreport rather than overreport illicit substance use during pregnancy 38 ; therefore, women who reported days of use in the top quartile were a priori considered heavier users, even if the meconium benzoylecgonine level was not in the top quartile because not all infants who are exposed to cocaine prenatally have positive meconium assays. 39 Moreover, meconium samples were not obtained from 14% of study infants; therefore, whichever indicator (self-report or meconium assay) demonstrated higher exposure was used to determine exposure category. For this study, we recruited participants from the parent sample of children had who IUCE and fit additional criteria listed next and whose intrauterine cocaine exposure was Ͼ1100 ng/g meconium, the parent sample median.
A total of 123 infants were initially identified by perinatal clinicians as cocaine exposed on the basis of maternal antepartum or peripartum urine drug screen cocaine metabolite results. Five of 134 infants who were clinically considered to be cocaine unexposed were excluded from the final sample because no confirmatory biological marker was available, and 15 others were reclassified because urine or meconium assays were positive for cocaine metabolites, leaving 114 unexposed infants in the sample. In all, 138 infants were found to demonstrate evidence of IUCE. Together, the unexposed and exposed infants constituted a neonatal study sample of 252 initially consented. In all, 216 (86%) of the neonatal sample had meconium assays performed. No infant demonstrated amphetamine, opiate, or phencyclidine exposure by urine or meconium assay or by maternal report.
The Addiction Severity Index, a validated tool for substance abuse report, as well as additional study-specific interview questions was used to determine maternal alcohol, cigarette, and marijuana use during pregnancy. 40 Alcohol, cigarette, and marijuana use was reported as number of drinks per week; number of cigarettes smoked per day; and number of days of use of alcohol, cigarettes, and marijuana, respectively, during the last 30 days of pregnancy. Data were acquired similarly for use of these substances during pregnancy before the last 30 days. This permitted determination and use of average daily volume and average daily cigarettes for alcohol and cigarette use, respectively. Because marijuana is stored for long periods in body fat, marijuana metabolite concentration in meconium constitutes a less valid indication of total dosage than that of cocaine metabolites. 37 In addition, one third of the marijuana users identified on the basis of meconium/urine assay denied its use on interview. Consequently, construction of a reliable index of marijuana dosage proved difficult. In the following analyses, marijuana exposure was coded as exposed or unexposed on the basis of any positive selfreport or any positive urine/meconium assay.
Cohort Selected for MRI
We recruited children for this study from the parent sample who were African American/African Caribbean until a sample size of 40 was attained, 16 with IUCE Ͼ1100 ng/g meconium, the parent sample median, and 24 otherwise demographically comparable children who had no IUCE. All children were right-handed. In addition to the initial exclusion criteria, the sample for this neuroimaging study excluded children with the following complications that might confound MRI interpretation: (1) history of central nervous system radiation, (2) loss of consciousness after head trauma, (3) history of seizures, (4) history of lead poisoning requiring chelation therapy, (5) history of intracranial surgery, and (6) history of systemic illness or medical treatment that might adversely affect brain structure. Children were recruited after parent/guardian informed consent and child assent were obtained using protocols approved by the Boston Medical Center institutional review board and the Committee on Clinical Investigation of Children's Hospital Boston.
MRI Scans
Each of the 40 children underwent imaging using a 1.5 T GE LX MR scanner (GE, Milwaukee, WI) operating at the GE 12.0 platform at Children's Hospital Boston. No sedation was used for image acquisition, but patients were acclimatized to the scanner environment. After a T1-weighted localizing scan was obtained, a high-resolution 3-dimensional T1-weighted Fourier Transform Spoiled Gradient neuroanatomic whole-brain acquisition was obtained (24 cm 
MRI Quality
Complete data sets were obtained from all 40 children scanned. Each raw data set was reviewed by a member of the research team (Dr Rivkin) for data quality. A neuroradiologist blinded to the identity of study children (Dr Robson) provided a clinical reading of each MRI data set. Scans of 5 children (2 with IUCE, 3 control subjects) possessed unacceptable movement artifact precluding their further analysis. Thus, 35 children (14 with IUCE, 21 without IUCE; 88% of children scanned) produced data sets that were fully analyzed.
Postimaging Data Analysis
Postimaging data processing and quantitative volumetric analyses were conducted on computer workstations using a LINUX platform. A sequence of established and validated image processing algorithms was used to segment each of the MRI slices into separate tissue classes. [41] [42] [43] [44] [45] [46] Briefly, each MRI slice in each data set was segmented into cerebral cortical gray matter (CGM), subcortical gray matter (SCGM; to include caudate, putamen, globus pallidus, and substantia nigra, bilaterally), white matter (WM), and cerebrospinal fluid (CSF; including ventricular and extra-axial CSF). These algorithms were designed to reduce imaging system noise, identify a linear transformation, and resample the DE spin-echo images according to the aforementioned linear transform to align the coronal DE spin-echo images with the coronal spoiled gradient images to form a 3-channel data set to classify tissue types on the basis of the MR intensity in the 3 channels and identify tissueclass surfaces for 3-dimensional visualization. From tissue segmentation of each slice, whole-brain absolute tissue volumes were determined in milliliters for CGM, WM, SCGM, and CSF (Fig 1) , permitting calculation of total parenchymal volume (TOT; CGM ϩ WM ϩ SCGM) and total intracranial volume (TICV; CGM ϩ WM ϩ SCGM ϩ CSF). Data were examined both as volumes referenced to TICV and as absolute volumes.
Segmentations and volumetric analyses were undertaken by 2 members of the research team (Mr Davis and Ms Lemaster) and reviewed by a third team member (Dr Rivkin), all of whom were masked to subject group membership. Reviewers' consistency in tissue classification was assessed throughout the study with no more than 4% variance in tissue volumes found on quality certification data sets performed by both reviewers.
Data Analysis
All volumetric data and head circumference measurements were included in analysis. To ensure comparability with the cocaine variable, alcohol, tobacco, and marijuana were also collapsed to exposed/unexposed. First, bivariate analyses were performed to examine the effect of each individual exposure on HC and brain tissue volumes without adjustment for demographic variables or other exposures. Second, an initial multiple linear regression analysis discerned the effect of each individual exposure adjusted for child's gender and age at scan (demographic features). Such adjustment was performed because age and gender can affect brain size. Given that the children studied were both male and female and represented ages ranging from 10 to 13.8 years, adjustment for these features was essential to avoid misattribution of possible effects of age and gender to prenatal drug exposures. Because the impact of the birth mother's level of highest educational attainment was tested and found not to correlate with any outcome, it was not retained in final models. Third, a second-level, multiple linear regression analysis for each exposure incorporated the first model and adjusted for the remaining exposures. Thus, for comparison of children with IUCE and those with none, mean values were adjusted for gender and age at scan as well as for simultaneous cigarette, alcohol, and marijuana exposure. Similarly, for comparison of children with intrauterine alcohol exposure and those with none, mean values were adjusted for demographic features as well as for simultaneous cocaine, cigarette, and marijuana exposure. Similar analyses were conducted for intrauterine cigarette exposure and for intrauterine marijuana exposure. Associations with 2-tailed P Ͻ .05 were judged to be statistically significant.
Small HC in bivariate analyses was associated with each of the 4 substance exposures studied (see "Results"). Because HC has been demonstrated to correlate with brain volumes, analyses were performed using absolute volumes. [47] [48] [49] Analyses were also performed using a ratio of absolute tissue volumes divided by TICV, which yielded no statistically significant differences among groups for any of the cerebral tissue outcome variables; however, children who were exposed to cocaine, to alcohol, and to cigarettes each demonstrated reductions in HC at the time of measurement that were statistically significant as compared with control subjects. Furthermore, significant reduction of HC was found in children who were exposed prenatally to Ն2 of these substances. Because the principal determinant of head size is brain size and because reduction of HC accompanied prenatal drug exposure for the majority of the exposed children, we reasoned that adjustment for HC or its proxy, intracranial cavity volume, factored out the effect of the exposure as well. As a result, all analyses were performed using absolute tissue volumes.
RESULTS
Subjects
Thirty-five children were included for final analysis of MRI data. The group comprised 14 children with IUCE and 21 with no IUCE. Characteristics of children in the study sample are provided in Table 1 . Among the children with IUCE, prenatal exposures to maternally used alcohol, cigarettes, or marijuana were common; however, 8 (38%) children with no IUCE had prenatal exposures to alcohol, cigarettes, or marijuana as well. Multiple prenatal exposures occurred in 15 of the 35 children studied. Among children with IUCE, 11 (78.5%) of the 14 had prenatal exposure to Ն2 of the other substances studied, whereas only 2 (9.5%) of the 21 children with no IUCE had such exposures. Finally, 43% of the children in the exposed group of this study had exposures to cocaine and 2 other substances, whereas 35% had exposures to cocaine and the 3 other substances (Table 2).
Children with IUCE demonstrated significantly smaller HC than those with no IUCE in both the unadjusted analysis (53.4 No difference between groups was observed for WM, SCGM, or CSF volumes in both the unadjusted analysis and the analysis that was adjusted for demographics (Table 3) .
Children with prenatal marijuana exposure demonstrated a trend toward smaller mean HC as compared with those with no prenatal marijuana exposure in both the unadjusted analysis and the analysis that was adjusted for demographics, but the difference did not reach significance. Although CGM and TOT were reduced in the unadjusted analysis and the analysis that was adjusted for demographic features, only in the unadjusted (Table 3) . After the foregoing unadjusted and first-level multiple regression analyses, a second multiple regression analysis for each exposure was performed and incorporated the first model and added adjustments for the remaining exposures. It is interesting that although the trend for group differences in cerebral tissue volumes persisted, the individual effects of cocaine and alcohol, respectively, were no longer statistically significant after controlling for the other exposures. Notably, CGM and TOT remained reduced and retained marginal significance (CGM: P ϭ .08; TOT: P ϭ .09) in the analysis of intrauterine cigarette exposure after adjustment for simultaneous exposures to cocaine, alcohol, and marijuana (see Table 3 for summary of intergroup differences by substance for the unadjusted and both adjusted analyses).
Additional analysis was performed to compare children who were exposed prenatally to Ն2 substances with control subjects, adjusted for gender and age at examination. This analysis revealed significant reductions in CGM, TOT, and HC (776 mL vs 841 mL [P ϭ .004]; 1175 mL vs 1269 mL [P ϭ .007]; 53.4 cm vs 55.7 cm [P ϭ .02], respectively; Table 4 ). Next, analysis of variance was performed to examine the cumulative effect on CGM, TOT, and HC of prenatal exposure to Ն1 of these substances (Table 5 ) as compared with nonexposed children with the independent variable the count of the number of substances to which the child was exposed in utero. A global mean P value for the analysis of variance models of .01 for both CGM and TOT indicated that reductions in these volumes relative to the unexposed were significantly associated with number of substances of exposure. A similar pattern was apparent for HC, which demonstrated a global mean P ϭ .07. Table 5 demonstrates that CGM, TOT, and HC all declined as the number of substances to which study children were prenatally exposed exceeded 1. Indeed, this analysis of variance demonstrated that the smallest volumes of CGM, TOT, and HC were found in association 1190 (24) 1262 (19) .020 b 782 (15) 830 (12) .020 b 364 (14) 388 (11) . 1214 (19) 1246 (22) .450
800 (18) 817 (14) .510
369 (17) 385 (13) . (69) 836 (65) . 1177 (28) 1259 (19) .030 b
776 (18) 826 (12) .030 b 357 (17) 389 (11) . 1215 (34) 1242 (20) .550
803 (21) 814 (13) .710
368 (21) 384 (12) . 1191 (20) 1278 (20) .005 b
782 (12) 840 (13) .003 b 366 (12) 392 (13) . 1201 (23) 1268 (24) .090
789 (15) 833 (15) .080
368 (14) 390 (15) . 1217 (29) 1241 (20) .520
789 (18) 820 (12) .170
385 (17) 376 (11) . 1252 (29) 1225 (19) .460
810 (18) 811 (12) .960
400 (18) 369 (11) . .970 E indicates exposed; NE, nonexposed. All HC values reflect group means of individual HC measurements obtained from each child at 10.5 years of age. a P value for significance level of corresponding tissue volume difference between E and NE groups (P values are 2-tailed).
b P values statistically significant at the .05 level. 
DISCUSSION
In this study, multiple regression analyses of absolute brain tissue volumes and head size revealed that prenatal exposures to cocaine, alcohol, and cigarettes individually were associated with reductions in HC and CGM and TOT volumes in 10-to 14-year-old children relative to comparison subjects after controlling for age at scan and gender. Importantly, these reductions reached bivariate statistical significance for cocaine, alcohol, and cigarette exposures, individually. Additional analyses of each exposure in which additional adjustment was made for the remaining 3 exposures revealed that the observed trend to reductions in CGM and TOT volumes associated with prenatal cocaine or alcohol exposure persisted but was no longer statistically significant. In distinction, the effects of prenatal cigarette exposure on CGM and TOT retained marginal significance despite such adjustment (P ϭ .08 and .09, respectively). Last, analysis of variance provided evidence of an inverse relationship between the number of substances to which these children were prenatally exposed and the reduction found in CGM, TOT, and HC. To our knowledge, this is the first volumetric magnetic resonance neuroimaging study to report wholebrain parenchymal volume and CGM volume reductions in older children that may be related to the individual effects of multiple intrauterine exposures, including cocaine. Our data indicate that, in addition to cocaine, prenatal exposures to tobacco and alcohol could play roles individually or in combination with IUCE in the observed brain tissue volume and HC reductions.
These findings are consistent with those of other investigators. Diminished HC has been linked repeatedly to intrauterine exposure. Prenatal cocaine exposure has been associated with reduced HC at birth 14, 50, 51 with both an inverse dosage effect and trimester-specific effects of prenatal cocaine exposure on HC reported. 3, 52, 53 Similarly, maternal cigarette use has been associated with significant reduction of newborn HC. 54, 55 Finally, prenatal alcohol exposure during pregnancy has been associated with reduced HC both at birth and as late in childhood as 14 years of age 56, 57 in children who do not manifest physical features of FAS.
The reported reductions of both CGM and TOT volumes are consistent with other observations about brain structure reported with respect to intrauterine exposures to cocaine, alcohol, cigarettes, or marijuana. Use of recently developed quantitative neuroimaging techniques to study the brain structure and function of children with IUCE has been limited. In the parent sample of this study, cranial ultrasonography revealed that neonates who were exposed to higher (top quartile) levels of prenatal cocaine demonstrated more frequent occurrence of caudothalamic groove subependymal hemorrhage than was found in lighter exposed or unexposed newborns after adjustment for a variety of confounding variables, including prenatal exposure to cigarettes, alcohol, and marijuana. 36 Other studies using similar samples have shown no such effects. 58 Use of MRI morphometry and magnetic resonance spectroscopy to examine the subsequent effect of IUCE on the brain of school-age children showed no morphometric difference between children with and without IUCE; however, frontal WM creatine was elevated by magnetic resonance spectroscopy in children with IUCE. 59 Although concomitant exposures to cigarettes or alcohol were recognized in both groups, statistical adjustment for these exposures was not attempted. Another study that sought correlation between cognitive performance and mean diffusivity measured with diffusion tensor imaging found higher mean diffusivity in anterior callosal and right frontal projection fibers and lower scores on executive function measures among children who had IUCE compared with those without such exposure. 60 Notably, these investigators found that prenatal exposures to alcohol and marijuana as well as an interaction between prenatal exposures to marijuana and cocaine affected prefrontal WM mean diffusivity. Although we found an association between alcohol exposure and WM volume in the bivariate analysis of this study, we did not find any group differences in WM volume associated with cocaine exposure; however, our data are volumetric and do not include diffusion tensor imaging and spectroscopy data. Similarly, compelling evidence supports the deleterious effect of prenatal alcohol exposure on brain development. Neuropathologic study of brain from children with FAS indicated alcohol-associated derailment of the migrational phase of normal brain development. These findings included microcephaly, widespread leptomeningeal heterotopias, and schizencephaly. 61, 62 In addition, midline WM abnormalities such as agenesis and dysgenesis of the corpus callosum as well as septo-optic dyspla- All P values are 2-tailed. Numbers in parentheses are P values for difference between exposure group and group with no prenatal substance exposure; prenatal exposures are cocaine, cigarettes, alcohol, and marijuana. ANOVA indicates analysis of variance.
sia have been found on autopsy and in vivo through MRI study. 63, 64 Volumetric MRI studies of children with prenatal exposure to alcohol including children without stigmata of FAS revealed reduced intracranial vault size; volume reduction of corpus callosum, basal ganglia, and cerebellum; and abnormal ratios of gray matter to WM in temporoparietal regions of brain, persistent even in adolescence. [65] [66] [67] [68] [69] [70] [71] [72] A growing body of evidence indicates a lasting adverse effect of prenatal exposure to maternal cigarette use. Mammalian studies demonstrated that prenatal exposure to nicotine can upregulate nicotinic cholinergic receptors in developing brain, shortening the proliferative phase of brain development and thereby allowing earlier onset of neuronal differentiation as compared with comparison subjects. 73, 74 Volumetric MRI study of brain tissue volumes in adult smokers as compared with nonsmokers revealed reduced gray matter volume in prefrontal cortex in both hemispheres and left anterior cingulate. 75 Although these findings related to postnatal cigarette exposure could represent effects of chronic smoking, predisposing traits that lead to smoking, or some combination of these factors, they raise the possibility that prenatal cigarette exposure may exert structural consequences on developing brain.
Data are less available regarding the structural consequences of prenatal marijuana exposure on brain development. Wilson et al 76 raised the question of developmental sensitivity of brain to marijuana exposure in their volumetric MRI study that demonstrated proportionately less CGM and more WM in children who initiated marijuana use before the age of 17 as compared with those who did not use marijuana or who initiated use after the 17 years of age.
The limitations of this study must be recognized. First, because not all cases had drug screens from both members of each dyad (urine from mothers and urine or meconium from control infants), we cannot exclude the possibility that in addition to those who were reclassified after recruitment because of positive screen results, there were other exposed children misclassified as "controls." Second, our definition of heavy cocaine exposure (top quartile for this sample, Ն61 days of reported use during pregnancy) differed from the definition used by others in other cohorts to define heavy cocaine use (Ն2 times per week throughout pregnancy), and it is, therefore, possible that our inability to detect an effect of heavy exposure on HC or brain tissue volumes in the analysis adjusted for both demographic and other substance exposures may have been attributable to a cohort that was overall less heavily exposed than some other cohorts. 77, 78 Comparisons across cohorts are difficult because the potency and contamination of illicit substances, such as cocaine, vary across time and by geographic location so that number of days of use can only approximate the actual "dosage" experienced by the fetus. Third, the total number of children studied was small. This small number prohibits determination of interactions among the prenatal exposures that may have affected the outcomes. Furthermore, stratification by gender was not possible. Finally, the sample studied was exclusively African American or African Caribbean and poor; therefore, generalization of these findings to the general population of children in the United States is not possible at this time. It is possible that study of a larger sample would allow effects of individual and combined prenatal exposures on the MRI outcome measures to emerge that are not apparent now.
Our data indicate that prenatal exposures to cocaine, cigarettes, and alcohol may each individually exert an adverse effect on CGM and TOT volumes that can be detected subsequently in children who are 10 to 14 years of age using volumetric MRI. Furthermore, prenatal exposures to these substances in combination may exert deleterious and lasting consequences on brain structure. Prenatal exposure to increasing numbers of substances was associated with significant reduction in TOT, CGM, and HC. Although firm conclusions about the discrete individual effects of prenatal cocaine, alcohol, or cigarettes on brain volume in the children of our small sample cannot be made, these data are consistent with a possible, lasting effect of each and raise concern that exposure to combinations of these 4 substances during the prenatal period may have an enduring effect on brain structure in children.
The clinical implication of these results suggests that prenatal care and counsel of pregnant women not only should include emphasis on the potential lasting consequences on children of use of individual substances (whether legal or illegal) by their pregnant mothers but also should stress that substances such as cocaine, cigarettes, alcohol, and marijuana may produce cumulative effects on brain structure that are detectable at school age. Furthermore, assistance should be offered to reduce use of all of these substances. From a scientific perspective, additional systematic neuroimaging studies of larger samples are needed to clarify the effect of dosage of each substance, threshold of effect, interaction of substances with each other, and potential moderating effects of demographic variables such as age and gender.
